2McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998, 351 :9-13.
3Shirakami G, Nakao K, Yamada T,et al. Inhihitory effect of brain natriuretic peptide ca central angiotensin Ⅱ-stimulated pressor response in conscious rats. Neurosci Lett,1988,91:77-83.
4Zeldel ML. Hormonal regulation of inner medullary collecting duct sodium transport. Am J Physiol, 1993, 265 (2 Pt2) :F159-173.
5Atarashi K, Mulrow PJ, Franco-Saenz R. Effect of atrial peptides on aldosterone production. J Clin Invest, 1985,76:1807-1811.
6Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998.339:321-328.
7Berger R, Huelsmann M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure-A selection mode for ICD implantation. J Am Coil Cardiol, 2002, 39(suppl B) : 193B.
8Anand I, Latini R, Masson S, et al. The predictive value of combinations of different levels of BNP and NE in the val-HeT trial.J Am Coll Cardiol. 2002,39 (suvvl B) : 406B.
9Hall C, Rouleau JL, Moye L, et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.Circulation,1994,89:1934-1942.
10Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
